Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy.

about

Estimating (131)I biokinetics and radiation doses to the red marrow and whole body in thyroid cancer patients: probe detection versus image quantification.A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance.

P2860

Q37079244-84005FB6-305F-49DE-B9A9-5F2B375F707E Q47135159-7F24B91D-53A7-47F6-8384-64DC619A58A8

P2860

Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy.

Item

http://www.wikidata.org/entity/Q50536307

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Comparison of different dosime ...... ion in thyroid cancer therapy.

@en

Comparison of different dosime ...... ion in thyroid cancer therapy.

@nl

type

Item

label

Comparison of different dosime ...... ion in thyroid cancer therapy.

@en

Comparison of different dosime ...... ion in thyroid cancer therapy.

@nl

prefLabel

Comparison of different dosime ...... ion in thyroid cancer therapy.

@en

Comparison of different dosime ...... ion in thyroid cancer therapy.

@nl

P1476

Comparison of different dosime ...... ion in thyroid cancer therapy.

@en

P2093

Carlos A Buchpiguel

http://www.w3.org/2001/XMLSchema#string

José Willegaignon

http://www.w3.org/2001/XMLSchema#string

Marcelo T Sapienza

http://www.w3.org/2001/XMLSchema#string

P2860

124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Treatment planning for molecular targeted radionuclide therapy.

Establishing a clinically meaningful predictive model of hematologic toxicity in nonmyeloablative targeted radiotherapy: practical aspects and limitations of red marrow dosimetry.

The impact of PET and SPECT on dosimetry for targeted radionuclide therapy.

Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer.

Absorbed doses in the marrow during 131I therapy.

Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetry.

A minimally invasive method to evaluate 131I kinetics in blood.

EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy.

P304

138-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RPD/NCR214

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51140754

http://www.w3.org/2001/XMLSchema#string

P698

21586539

http://www.w3.org/2001/XMLSchema#string

Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy.

about

P2860

P2860

Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698